Generic lamivudine and abacavir approved.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000008:administration & dosage / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D016568:Drugs, Generic; D019259:Lamivudine; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir